Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2

The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike prote...

Descripción completa

Detalles Bibliográficos
Autor principal: He, Jiahua et al.
Formato: Research protocol information
Publicado: 2020-04-10
Materias:
Acceso en línea:https://doi.org/10.3390/v12040428
https://hdl.handle.net/20.500.12663/1204
id PAO-20.500.12663-1204
record_format dspace
spelling He, Jiahua et al.
2020-04-24T18:03:13Z
2020-04-24T18:03:13Z
2020-04-10
https://doi.org/10.3390/v12040428
https://hdl.handle.net/20.500.12663/1204
The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike protein to ACE2. Here, we have systematically studied the molecular mechanisms of human infection with SARS-CoV-2 and SARS-CoV by protein-protein docking and MD simulations. It was found that SARS-CoV-2 binds ACE2 with a higher affinity than SARS-CoV, which may partly explain that SARS-CoV-2 is much more infectious than SARS-CoV. In addition, the spike protein of SARS-CoV-2 has a significantly lower free energy than that of SARS-CoV, suggesting that SARS-CoV-2 is more stable and may survive a higher temperature than SARS-CoV. This provides insights into the evolution of SARS-CoV-2 because SARS-like coronaviruses have originated in bats. Our computation also suggested that the RBD-ACE2 binding for SARS-CoV-2 is much more temperature-sensitive than that for SARS-CoV. Thus, it is expected that SARS-CoV-2 would decrease its infection ability much faster than SARS-CoV when the temperature rises. These findings would be beneficial for the disease prevention and drug/vaccine development of SARS-CoV-2.
English
COVID-19
Coronavirus
Infectious Diseases
SARS-CoV-2
Molecular Structure
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
Viruses
Others
Virus: natural history, transmission and diagnostics
Research protocol information
Save Lives / Salvar Vidas
elec_str_mv Organización Panamericana de la Salud
collection Organización Panamericana de la Salud
title Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
spellingShingle Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, Jiahua et al.
COVID-19
Coronavirus
Infectious Diseases
SARS-CoV-2
Molecular Structure
title_short Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
title_full Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
title_fullStr Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
title_full_unstemmed Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
title_sort molecular mechanism of evolution and human infection with sars-cov-2
author He, Jiahua et al.
author_facet He, Jiahua et al.
topic COVID-19
Coronavirus
Infectious Diseases
SARS-CoV-2
Molecular Structure
topic_facet COVID-19
Coronavirus
Infectious Diseases
SARS-CoV-2
Molecular Structure
publishDate 2020-04-10
format Research protocol information
description The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike protein to ACE2. Here, we have systematically studied the molecular mechanisms of human infection with SARS-CoV-2 and SARS-CoV by protein-protein docking and MD simulations. It was found that SARS-CoV-2 binds ACE2 with a higher affinity than SARS-CoV, which may partly explain that SARS-CoV-2 is much more infectious than SARS-CoV. In addition, the spike protein of SARS-CoV-2 has a significantly lower free energy than that of SARS-CoV, suggesting that SARS-CoV-2 is more stable and may survive a higher temperature than SARS-CoV. This provides insights into the evolution of SARS-CoV-2 because SARS-like coronaviruses have originated in bats. Our computation also suggested that the RBD-ACE2 binding for SARS-CoV-2 is much more temperature-sensitive than that for SARS-CoV. Thus, it is expected that SARS-CoV-2 would decrease its infection ability much faster than SARS-CoV when the temperature rises. These findings would be beneficial for the disease prevention and drug/vaccine development of SARS-CoV-2.
url https://doi.org/10.3390/v12040428
https://hdl.handle.net/20.500.12663/1204
work_keys_str_mv AT hejiahuaetal molecularmechanismofevolutionandhumaninfectionwithsarscov2
_version_ 1737882963132022784